Overview

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

Status:
Unknown status

Trial end date:
2018-02-01

Target enrollment:

Participant gender:

Summary

This study is intended to provide contemporary data on the residual cardiovascular risk in all consecutive patients with acute myocardial infarction, especially in patients who survived stably within one-year after percutaneous coronary intervention. In addition, this study will identify which baseline clinical, angiographic, or treatment factors are associated with residual cardiovascular risk and bleeding events

Details

Lead Sponsor:

Seoul St. Mary's Hospital

Collaborators:

AstraZeneca
Chonnam National University
The Catholic University of Korea